{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:27:09Z","timestamp":1793593629318,"version":"4.5.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Regional Research Council Uppsala\u2013\u00d6rebro","award":["72321"],"award-info":[{"award-number":["72321"]}]},{"name":"Center for Research and Development Uppsala University\/Region G\u00e4vleborg","award":["965453"],"award-info":[{"award-number":["965453"]}],"id":[{"id":"https:\/\/ror.org\/048a87296","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Uppsala University Hospital Research Fund","id":[{"id":"https:\/\/ror.org\/01apvbh93","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-982369"],"award-info":[{"award-number":["R-982369"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"name":"King Gustav Vth 80-year foundation","award":["FAI-2021-0823"],"award-info":[{"award-number":["FAI-2021-0823"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of the present study was to evaluate the performance of serum and SF levels of the granulocyte protein calprotectin as an inflammatory biomarker in RA patients with knee synovitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seventy-six RA patients with ongoing knee synovitis were included. Data on DAS with 28 joints and their subcomponents and radiological destruction of the affected knee were collected. White blood cell count, CRP, ACPA against cyclic citrullinated peptide version 2 (anti-CCP2), IgM RF and calprotectin were analysed in parallel in circulation and in SF. Counts of polynuclear and mononuclear cells were measured in SF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum (S)-calprotectin correlated more strongly than SF-calprotectin with inflammatory markers and disease activity. Instead, SF-calprotectin showed a strong correlation to SF counts of white blood cells, and especially to polymorphonuclear cell counts (Spearman\u2019s \u03c1\u2009=\u20090.72, P\u2009&amp;lt;\u20090.001). S-calprotectin showed markedly stronger correlation with inflammatory markers and disease activity in ACPA positive as compared with ACPA negative RA patients; a similar difference was observed for patients with and without IgM RF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The particularly strong association between circulating calprotectin and inflammation in ACPA positive RA is a new argument for a specific role for polymorphonuclear granulocytes\/neutrophils in this RA subset. Measurement of calprotectin in SF does not convey any additional benefit compared with measurement in the circulation in RA patients with knee synovitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead641","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T10:16:26Z","timestamp":1701339386000},"page":"126-132","source":"Crossref","is-referenced-by-count":11,"title":["Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7371-9671","authenticated-orcid":false,"given":"Kristina","family":"Sejersen","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Section of Clinical Chemistry, Uppsala University , Uppsala,","place":["Sweden"]},{"name":"Unilabs AB , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-7116","authenticated-orcid":false,"given":"Tomas","family":"Weitoft","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Uppsala University\/Region G\u00e4vleborg , G\u00e4vle,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Knight","sequence":"additional","affiliation":[{"name":"Section of Rheumatology, Department of Medical Sciences, Uppsala University Hospital , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rgen","family":"Lysholm","sequence":"additional","affiliation":[{"name":"Clinic of Rheumatology, Falun Hospital , Falun,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Section of Clinical Chemistry, Uppsala University , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-3226","authenticated-orcid":false,"given":"Johan","family":"R\u00f6nnelid","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"2025010608383754900_kead641-B1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"2025010608383754900_kead641-B2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.7555\/JBR.33.20190075","article-title":"Contribution of neutrophils in the pathogenesis of rheumatoid arthritis","volume":"34","author":"Zhang","year":"2019","journal-title":"J Biomed Res"},{"issue":"12","key":"2025010608383754900_kead641-B3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbamcr.2010.02.006","article-title":"iPLA2, a novel determinant in Ca2+- and phosphorylation-dependent S100A8\/A9 regulated NOX2 activity","volume":"1803","author":"Schenten","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2025010608383754900_kead641-B4","first-page":"273","article-title":"A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells","volume":"16(Suppl)","author":"Fagerhol","year":"1980","journal-title":"Bull Eur Physiopathol Respir"},{"key":"2025010608383754900_kead641-B5","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1016\/S0021-9258(20)89506-4","article-title":"Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells","volume":"266","author":"Edgeworth","year":"1991","journal-title":"J Biol Chem"},{"key":"2025010608383754900_kead641-B6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ajcp\/84.1.24","article-title":"Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leucocytes","volume":"84","author":"Dale","year":"1985","journal-title":"Am J Clin Pathol"},{"key":"2025010608383754900_kead641-B7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/17534259211069635","article-title":"Early kinetics of calprotectin in plasma following inguinal hernia surgery","volume":"28","author":"Sejersen","year":"2022","journal-title":"Innate Immun"},{"key":"2025010608383754900_kead641-B8","first-page":"1416","article-title":"A longitudinal study of the leucocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis","volume":"16","author":"Berntzen","year":"1989","journal-title":"J Rheumatol"},{"key":"2025010608383754900_kead641-B9","first-page":"133","article-title":"The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis","volume":"18","author":"Berntzen","year":"1991","journal-title":"J Rheumatol"},{"key":"2025010608383754900_kead641-B10","first-page":"859","article-title":"Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity","volume":"19","author":"Brun","year":"1992","journal-title":"J Rheumatol"},{"key":"2025010608383754900_kead641-B11","first-page":"59","article-title":"A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis","volume":"13","author":"Hammer","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"2025010608383754900_kead641-B12","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/art.11177","article-title":"Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis","volume":"48","author":"Frosch","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025010608383754900_kead641-B13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/096120339300200108","article-title":"Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity","volume":"2","author":"Haga","year":"1993","journal-title":"Lupus"},{"key":"2025010608383754900_kead641-B14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2006.064741","article-title":"Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis","volume":"66","author":"Hammer","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2025010608383754900_kead641-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1983.tb07522.x","article-title":"Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen","volume":"134","author":"Dale","year":"1983","journal-title":"Eur J Biochem"},{"key":"2025010608383754900_kead641-B16","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/ar1939","article-title":"The S100A8\/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis","volume":"8","author":"Sunahori","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"2025010608383754900_kead641-B17","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/rheumatology\/ket315","article-title":"IL-22\/IL-22R1 axis and S100A8\/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts","volume":"52","author":"Carri\u00f3n","year":"2013","journal-title":"Rheumatology"},{"key":"2025010608383754900_kead641-B18","first-page":"2523","article-title":"Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8\/14 heterodimer in rheumatoid arthritis synovial membrane","volume":"26","author":"Youssef","year":"1999","journal-title":"J Rheumatol"},{"key":"2025010608383754900_kead641-B19","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar4586","article-title":"Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis\u2014a prospective cohort study","volume":"16","author":"Weitoft","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025010608383754900_kead641-B20","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/rheumatology\/keu486","article-title":"Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies","volume":"54","author":"Weitoft","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608383754900_kead641-B21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2025010608383754900_kead641-B22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jama.1949.02900430001001","article-title":"Therapeutic criteria in rheumatoid arthritis","volume":"140","author":"Steinbrocker","year":"1949","journal-title":"J Am Med Assoc"},{"key":"2025010608383754900_kead641-B23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2025010608383754900_kead641-B24","first-page":"285","volume-title":"The recognition of antirheumatic drugs","author":"Larsen","year":"1978"},{"key":"2025010608383754900_kead641-B25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/03009748809098795","article-title":"Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire","volume":"17","author":"Ekdahl","year":"1988","journal-title":"Scand J Rheumatol"},{"key":"2025010608383754900_kead641-B26","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"key":"2025010608383754900_kead641-B27","first-page":"5","article-title":"The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis","volume":"31","author":"Yu","year":"2019","journal-title":"Ci Ji Yi Xue Za Zhi"},{"key":"2025010608383754900_kead641-B28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.coi.2006.06.004","article-title":"Genes, environment and immunity in the development of rheumatoid arthritis","volume":"18","author":"Klareskog","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"2025010608383754900_kead641-B29","doi-asserted-by":"crossref","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"key":"2025010608383754900_kead641-B30","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/annrheumdis-2012-202765","article-title":"Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps","volume":"73","author":"Pratesi","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025010608383754900_kead641-B31","doi-asserted-by":"crossref","first-page":"209ra150","DOI":"10.1126\/scitranslmed.3006869","article-title":"Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis","volume":"5","author":"Romero","year":"2013","journal-title":"Sci Transl Med"},{"key":"2025010608383754900_kead641-B32","doi-asserted-by":"crossref","first-page":"578129","DOI":"10.3389\/fimmu.2020.578129","article-title":"Neutrophil extracellular traps tied to rheumatoid arthritis: points to ponder","volume":"11","author":"Song","year":"2020","journal-title":"Front Immunol"},{"key":"2025010608383754900_kead641-B33","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI62423","article-title":"Alarmins: awaiting a clinical response","volume":"122","author":"Chan","year":"2012","journal-title":"J Clin Invest"},{"key":"2025010608383754900_kead641-B34","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat Med"},{"key":"2025010608383754900_kead641-B35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.1008647","article-title":"The endogenous Toll-like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer","volume":"86","author":"Ehrchen","year":"2009","journal-title":"J Leukoc Biol"},{"key":"2025010608383754900_kead641-B36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2013-203923","article-title":"MRP8\/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis","volume":"74","author":"Choi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025010608383754900_kead641-B37","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s10620-010-1494-9","article-title":"Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease","volume":"56","author":"Manolakis","year":"2011","journal-title":"Dig Dis Sci"},{"key":"2025010608383754900_kead641-B38","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1002\/art.20631","article-title":"Proinflammatory S100 proteins in arthritis and autoimmune disease","volume":"50","author":"Foell","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2025010608383754900_kead641-B39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12950-015-0090-3","article-title":"A new turbidimetric immunoassay for serum calprotectin for fully automatized clinical analysers","volume":"12","author":"Nilsen","year":"2015","journal-title":"J Inflamm (Lond)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead641\/54257124\/kead641.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/1\/126\/54257124\/kead641.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/1\/126\/54257124\/kead641.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T03:39:50Z","timestamp":1736134790000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/1\/126\/7458454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,4]]},"published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead641","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2023,12,4]]}}}